1CM
TNDM icon

1492 Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

1492 Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-188,754
Closed -$3.52M – 123
2025
Q2 		$3.52M Buy
188,754
+166,308
+741% +$3.29M 1.62% 18
2025
Q1 		$430K Buy
+22,446
New +$657K 0.23% 75
2023
Q3 		– Sell
-95,074
Closed -$2.33M – 110
2023
Q2 		$2.33M Sell
95,074
-81
-0.1% -$2.61K 1.36% 25
2023
Q1 		$3.86M Buy
95,155
+80,584
+553% +$3.34M 2.38% 11
2022
Q4 		$655K Sell
14,571
-422
-3% -$19.1K 0.42% 67
2022
Q3 		$717K Sell
14,993
-60
-0.4% -$3.29K 0.52% 64
2022
Q2 		$891K Buy
15,053
+4,681
+45% +$384K 0.59% 61
2022
Q1 		$1.21M Sell
10,372
-121
-1% -$14.1K 0.64% 55
2021
Q4 		$1.58M Sell
10,493
-5
-0% -$675 0.78% 48
2021
Q3 		$1.25M Sell
10,498
-165
-2% -$18.2K 0.63% 52
2021
Q2 		$1.04M Hold
10,663
– – 0.53% 63
2021
Q1 		$941K Buy
10,663
+569
+6% +$52.9K 0.54% 56
2020
Q4 		$966K Hold
10,094
– – 0.56% 57
2020
Q3 		$1.15M Buy
10,094
+646
+7% +$67.9K 0.86% 39
2020
Q2 		$935K Sell
9,448
-30
-0.3% -$2.39K 0.8% 37
2020
Q1 		$610K Buy
+9,478
New +$664K 0.73% 45

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

1492 Capital Management's TNDM Position: Q3 2025 in Review

1492 Capital Management sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 188,754 shares — an estimated $3.52M sold.

1492 Capital Management first reported a position in TNDM in Q1 2020 and held it in 16 quarters. The position peaked at $3.86M in Q1 2023. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • 1492 Capital Management reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • 1492 Capital Management sold 188,754 Tandem Diabetes Care shares in Q3 2025, an estimated $3.52M.
  • 1492 Capital Management first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 16 quarters.
  • 1492 Capital Management's Tandem Diabetes Care position peaked at $3.86M in Q1 2023.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on 1492 Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.